Home / Healing & recovery / GLOW (BPC-157 + TB-500 + GHK-Cu blend)
GlAnimal studies only

GLOW (BPC-157 + TB-500 + GHK-Cu blend)

GLOW is a mix of three peptides in one 70 mg vial: GHK-Cu, TB-500 and BPC-157. We found no human study of this mix, and little or no human data on each part when injected.

Not an approved medicineNo human trial of this blend
OverviewDosingMixingResearchCommunitySafetyFAQSources

GLOW (BPC-157 + TB-500 + GHK-Cu blend) quick reference

Type3-peptide blend (GHK-Cu, TB-500, BPC-157)
Studied forRepair and skin quality
EvidenceNo study of the blend
RouteInjection
Half-lifeNot established

What is GLOW (BPC-157 + TB-500 + GHK-Cu blend)?

One vial holding GHK-Cu, TB-500 and BPC-157.

People use it for tissue repair and skin quality.

The blend was never tested; each part has little injected human data.

How GLOW (BPC-157 + TB-500 + GHK-Cu blend) works

BPC-157 part

Rat tendon and blood-vessel work; no human proof.

TB-500 part

Short thymosin beta-4 piece tied to cell movement.

GHK-Cu part

Collagen and wound repair in the lab; human use is mostly on skin.

Blend idea

Each part acts on a different pathway in theory. Synergy is untested.

What GLOW (BPC-157 + TB-500 + GHK-Cu blend) is studied for

AnimalsTendon repair

Rats: BPC-157 or TB-500 helped Achilles healing; the pair added nothing.

PeopleKnee pain

BPC-157 (with or without TB4): 14 of 16 reported relief, uncontrolled.

PeopleDiabetic ulcers

GHK-Cu gel closed ulcers faster in a 1994 trial.

AnimalsSkin wounds

Thymosin beta-4 sped healing in diabetic and aged mice.

GLOW (BPC-157 + TB-500 + GHK-Cu blend) dosing protocol

ItemWhat is known
Human dose of the blendNot established
Studied inNever tested as a blend in people
Per 1 mg of powder (70 mg vial)About 714 mcg GHK-Cu, 143 mcg TB-500, 143 mcg BPC-157

The per-milligram split is our arithmetic from the stated 50 + 10 + 10 mg mix. It is not a trial or label amount.

HUMAN DOSENot establishedTrial
COMMUNITY RANGE1–4 mg of blend dailyCommunity
CYCLE4–6 weeksCommunity
PER 1 MG (50+10+10 VIAL)~714 mcg GHK-Cu, ~143 mcg each otherCommunity

Label and trial amounts come from the sources below. Community amounts are what people report; they have not been tested.

Mixing

Vial70 mg
+
BAC water3 mL
=
Strength≈23.3 mg per mL

Bacteriostatic water. Fixed ratio: you can't change one part alone.

Open the peptide calculator

What the research found

No human results exist for the blend or for its injected parts:

0human trials of this blend
0completed controlled trials of injected BPC-157 or TB-500
0human studies of injected GHK-Cu found

See the BPC-157, TB-500 and GHK-Cu pages for what each part has actually been tested for.

GLOW (BPC-157 + TB-500 + GHK-Cu blend) community experience

What users report. Not tested in trials.

Positive reports

  • One draw Users like one daily injection instead of three vials.
  • Skin and wounds Texture, hydration and wound look come up often.
  • Recovery comfort Some feel better during rehab and training.

Negative & mixed

  • Injection burn Burning, redness, welts or lingering irritation.
  • No change Some see nothing over a full cycle.
  • Locked ratio Can't lower one part without lowering all three.

GLOW (BPC-157 + TB-500 + GHK-Cu blend) stacking

GLOW vs separate vials

Separate vials let you set each amount, with more work.

GLOW vs KLOW

KLOW adds KPV. Neither is tested as a blend.

Ratio fit

A GHK-Cu-heavy mix may not suit a tendon-focused plan.

GLOW (BPC-157 + TB-500 + GHK-Cu blend) side effects & safety

Common

  • No safety data for the blend in people.
  • User reports: burning, redness or welts at the injection site.
  • User reports: headache, tiredness, nausea or flushing.
  • Three products in one vial add unknowns.

Less common

  • Allergic reaction, infection or contaminated product.
  • Long-term effects of copper and blood-vessel signals are unknown.

Precautions

  • Avoid in pregnancy, breastfeeding or under 18.
  • Avoid with active cancer or unexplained lumps.
  • Avoid with Wilson's disease or serious liver or kidney disease.
  • Tested athletes: BPC-157 and TB-500 are banned.
  • Known allergy to any ingredient.

Our verdict on GLOW (BPC-157 + TB-500 + GHK-Cu blend)

Convenient, but a fixed mix of three unproven injectables. Nobody has tested the blend.

GLOW (BPC-157 + TB-500 + GHK-Cu blend) FAQ

What is in GLOW?

A common vial: 50 mg GHK-Cu, 10 mg TB-500, 10 mg BPC-157.

Is GLOW proven?

No. We found no study of the blend.

Is GLOW better than separate vials?

Not shown. Separate vials only give more control.

Sources

  • Same sources as the BPC-157, TB-500 and GHK-Cu pages
  • Composition arithmetic: 50 / 70 mg = 714 mcg per mg; 10 / 70 mg = 143 mcg per mg
  • Bicer O et al. Jt Dis Relat Surg 2026 (BPC-157 and TB-500 together in rats), PMID 42542926
  • Lee E, Padgett B. Altern Ther Health Med 2021 (BPC-157 knee pain), PMID 34324435
  • Philp D et al. Wound Repair Regen 2003 (thymosin beta-4 in mouse wounds), PMID 12581423